항암화학치료 후 발생한 호중구 감소증에 대한 사물탕가감방 증례 보고
Recovery From Chemotherapy Induced Neutropenia Treated with Samul-tanggagambang
0
조회
0
다운로드
3
인용
0
참고문헌
키워드
초록
The purpose of this study is to report two patients with neutropenia caused by chemotherapy who prescribed Samul-tanggagambang. Samul-tanggagambang was prescribed three times a day to two patients with chemotherapy induced neutropenia. Complete blood cell count is measured before and after prescription. Absolute Neutrophil Count (ANC) was gradually increased after administration of Samul-tanggagambang to the cancer patients. Significantly, no related adverse events were found. Samul-tanggagambang has shown benefit in improving chemotherapy induced neutropenia. It is expected to be a promising treatment for improving chemotherapy induced neutropenia and more clinical research will be required for evidence based using.
Abstract
The purpose of this study is to report two patients with neutropenia caused by chemotherapy who prescribed Samul-tanggagambang. Samul-tanggagambang was prescribed three times a day to two patients with chemotherapy induced neutropenia. Complete blood cell count is measured before and after prescription. Absolute Neutrophil Count (ANC) was gradually increased after administration of Samul-tanggagambang to the cancer patients. Significantly, no related adverse events were found. Samul-tanggagambang has shown benefit in improving chemotherapy induced neutropenia. It is expected to be a promising treatment for improving chemotherapy induced neutropenia and more clinical research will be required for evidence based using.
참고문헌 (20)
- Bodey G. P., "Quantitative relationships between circulating leucocytes and infection in patients with acute leukemia", Ann Intern Med, 64(2), pp.328~339 (1966)
- Lee, B. R., "The effects of Sakunjatang and Samultang Aqua-acupuncture on immune response", K.O.M.S, 18(1), pp.357~374 (1997)
- 조성기, "면역조혈계 및 재생조직의 방사선 손상에 대한 생약복합물(HIM-I)의 방호 효과", 한국식품영양과학회지, 34(5), pp.605~612 (2005), 한국식품영양과학회
- Xu, X., "Effects of taohong siwu decoction II in the chick chorioallantoic membrane(CAM)assay and on B16 melanoma in mice and endothelial cells ECV304 proliferation", J Tradi Chin Med, 26(1), pp.63~67 (2006)
- Li, R., "Experimental study on preventive effect of traditional Chinese medicine replenishing recipe on acute oxygen toxicity caused by hyperbaric oxygen", Zhongguo Zhongxiyi Jiehe Zazhi, 18(10), pp.623~625 (1998)
- 이호영, "사물탕, 사군자탕, 팔물탕, 십전대보탕의 약리 활성 비교 연구", 동의신경정신과학회지, 21(4), pp.41~51 (2010), 대한한방신경정신과학회
- Kim, S. H., "Effect of Si-Wu-Tang and Si-Jun-Zi-Tang on the Survival of Jejunal Crypt Cells and Hematopoietic Cells in Irradiated Mice", J Korean Soc Food Sci Nutr, 30(4), pp.888~894 (1998)
- 조성기, "방사선에 대한 생약복합조성물(HemoHIM)의 재생조직 및 면역계 방호·회복촉진 효과", 한국식품영양과학회지, 34(6), pp.805~813 (2005), 한국식품영양과학회
- Howard, O, "2000 update of recommendations for the use of hematopoietic colony-stimulating factors: evidence-based, clinical practice guidelines", J Clin Oncol, 18(20), pp.3558~3585 (2000)
- Balducci, L, "Myelosuppression and its consequences in elderly patients with cancer", Oncology, 17(11 Suppl 11), pp.27~32 (2003)
- Link, B. K., "Delivering Adjuvant Chemotherapy to Women with Early-Stage Breast Carcinoma", Cancer, 92(6), pp.1354~1367 (2001)
- US Department of Health and Human Services, "Common Terminology Criteria for Adverse Events (CTCAE) Version 4.0", ~ (2010)
- Lalami, Y., "Can we predict the duration of chemotherapy-induced neutropenia in febrile neutropenic patients, focusing on regimen-specific risk factors? A retrospective analysis", Annals of Oncology, 17(3), pp.507~514 (2005)
- Blay, J. Y., "Early lymphopenia after cytotoxic chemotherapy as risk factor for febrile neutropenia", J Clin Oncol, 14(2), pp.636~643 (1996)
- Camp-Sorrell, D.A.W.N., "Core curriculum for oncology nursing", pp.259~274 (2005), St. Louis, Elsevier Saunders
- 김동우, "補中益氣湯加味方이 cyclophosphamide 투여로 인한 골수손상의 억제 및 회복에 미치는 영향", 동의생리병리학회지, 19(3), pp.736~742 (2005), 한의병리학회
- Shim, S. H., "Influences on the Anticancer and Inhibitive Effects of the Secondary Effects by Anticarcinogen of Shibyukmiyouki-Eum", J of Oriental Medical Surgery, Ophthalmology & Otolaryngology, 15(2), pp.302~314 (2002)
- 정승민, "黃芪추출물의 前投與가 Cyclophosphamide로 유발된 호중구 감소증에 미치는 영향", 대한한방내과학회지, 28(1), pp.1~11 (2007), 대한한방내과학회
- Tigue, C. C., "Granulocyte-colony stimulating factor administration to healthy individuals and persons with chronic neutropenia or cancer: an overview of safety considerations from the Research on Adverse Drug Events and Reports project", Bone Marrow Transplant, 40(3), pp.185~192 (2007)
- 선승호, "암환자의 방사선 요법 및 화학요법 치료 후 발생된 백혈구감소증의 치료에 관한 중의학 임상논문의 문헌적 고찰", 대한한방내과학회지, 23(1), pp.171~122 (2002), 대한한방내과학회